Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  ANTA PHAR       

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 0,54 M
EBIT 2015 -35,3 M
Net income 2015 -35,5 M
Debt 2015 -
Yield 2015 -
Sales 2016 3,79 M
EBIT 2016 -49,2 M
Net income 2016 -49,5 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 543x
Capi. / Sales 2016 77,5x
Capitalization 294 M
More Financials
Company
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat treat serious and life-threatening diseases, including lupus, lupus with glomerulonephritis, IgA nephropathy, and exocrine pancreatic insufficiency due to cystic... 
Sector
Pharmaceuticals
Calendar
11/03Earnings Release
More about the company
Latest news on ANTA PHAR
08/17 ANTHERA PHARMACEUTICALS : Entry into a Material Definitive Agreement, Financial ..
08/11 ANTHERA PHARMACEUTICALS : Reports 2015 Second Quarter and Operational Update
08/11 ANTHERA PHARMACEUTICALS : Reports 2015 Second Quarter and Operational Update
08/10 ANTHERA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
08/10 ANTHERA PHARMACEUTICALS : reports 2Q loss
08/10 ANTHERA PHARMACEUTICALS : Results of Operations and Financial Condition (form 8-..
08/10 ANTHERA PHARMACEUTICALS : Reports 2015 Second Quarter and Operational Update
07/31 ANTHERA PHARMACEUTICALS : to Report 2015 Second Quarter and Operational Update o..
More news
Sector news : Biopharmaceuticals
08:10p BRISTOL MYERS SQUIBB : -Myers, QIMR Collaborate To Discover Novel Immuno-Oncolog..
07:01p BRISTOL MYERS SQUIBB : and QIMR Berghofer Medical Research Institute Announce Wo..
10:08a NOVO NORDISK A/S : EDITORIAL: Will we invest in ourselves to create jobs?
More sector news : Biopharmaceuticals
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions